Histone deacetylase inhibition as a mechanism for the therapeutic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors) in follicular lymphoma. uri icon

Overview

publication date

  • June 21, 2010

Research

keywords

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Histone Deacetylase Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lymphoma, Follicular

Identity

Scopus Document Identifier

  • 77956256698

Digital Object Identifier (DOI)

  • 10.1200/JCO.2010.28.9488

PubMed ID

  • 20566995

Additional Document Info

volume

  • 28

issue

  • 24